The Eph family of receptors, the largest subgroup within the tyrosine protein kinase receptor family, are comprised of at least thirteen members, many of which are predominantly expressed in the developing and adult nervous system. In this study, we have isolated a fulllength cDNA, encoding the mouse homologue of a previous partially characterized Eek protein, a member of Eph receptor tyrosine kinase family. In a comparison of the amino acid sequences of various Eph family members, Eek is most similar to Ehk-3/MDK1, Sek/Cek8, Ehk-2, Hek/ Mek4/Cek4, and Bsk/Ehk1/Rek7/Cek7, which are predominantly expressed in the nervous system. Additionally, we have used a low-stringency PCR cloning technique to identify ligands, related to B61, that may interact with Eek. Three dierent GPI-linked ligands, namely Elf-1/ Cek7-L, Ehk1-L/E¯-2/Lerk3 and AL-1/RAGS, were isolated from mouse brain. To study the functional interactions between these ligands and the Eek receptors, we have constructed chimeric ligands consisting of the Fc portion of human IgG fused to their carboxyl-terminus. These chimeric ligands bound to, and activated both the Eek receptors and the Eek-TrkB chimeric receptors expressed in NIH3T3 cells. These ®ndings suggest that Eek receptor can be activated by at least three dierent GPI-linked ligands.
Introduction
Receptor tyrosine kinases and their ligands play pivotal roles in many dierent processes including proliferation, dierentiation and cell survival (van der Geer et al., 1994) . The receptor tyrosine kinases share general structural features, including an extracellular ligandbinding domain, a hydrophobic transmembrane region and an intracellular domain which contains the tyrosine kinase catalytic activity. Their intrinsic tyrosine kinase is activated upon ligand binding, thereby triggering complex signaling pathways which include the tyrosine-phosphorylation of various cellular substrates which act as second messengers. Ultimately, the activation of signaling pathways involving these molecules leads to a change in gene expression and phenotypic state of the cell.
Receptor tyrosine kinases have been grouped into fourteen subfamilies on the basis of both sequence homology and shared structural motifs (van der Geer et al., 1994) . The Eph-related receptors represent one subfamily characterized by their extracellular domain containing an immunoglobulin-like domain, one cysteine-rich region and two ®bronectin type III repeats. This family, with at least thirteen members, represents the largest subclass of receptor tyrosine kinases (Tuzi and Gullick, 1994; Pandey et al., 1995a; Friedman and O'Leary, 1996) . Some of the Eph family members are predominantly expressed in the developing brain (e.g. Elk/Cek6, Lhotak et al., 1991 ; Hek/Mek4/Cek4, Sajjadi et al., 1991; Sek/Cek8, Gilardi-Hebenstreit et al., 1992; Nieto et al., 1992 ; Bsk/Ehk1/Rek7/Cek7, Maisonpierre et al., 1993; Zhou et al., 1994; Ehk-2, Maisonpierre et al., 1993; Eek, Chan and Watt, 1991) . Other members (e.g. Eph, Hirai et al., 1987; Maru et al., 1988; Eck/Sek2, Lindberg and Hunter, 1990 ; Cek5/Erk/Nuk, Pasquale, 1991 , Pasquale et al., 1992 ; Hek2/Sek4/Cek10, Bohme et al., 1993; Htk/Myk1, Bennett et al., 1994; Ehk-3/MDK1, Valenzuela et al., 1995; Ciossek et al., 1995) are expressed in a broader range of tissues including lung, kidney, and intestine, as well as brain. Studies involving functional roles for the Eph-related receptors expressed in the developing brain or other tissues have been dicult until the recent ®ndings of their ligands. Seven dierent ligands for the Eph-related receptors have been discovered by expression cloning and protein puri®cation (Pandey et al., 1995b; Tessier-Lavigne, 1995; Friedman and O'Leary, 1996) . Five of the ligands are membranebound through a GPI-anchor, whereas the other two are membrane-bound through their own transmembrane domain. Interestingly, in contrast to their receptors, the expression of the ligands in tissues appears to be more widespread. In addition, binding studies have shown that any particular ligand in this family has a promiscuity for many of the Eph-related receptors, in some cases, with dierent anities. B61, the ®rst ligand identi®ed in this family, has been shown to act as an angiogenic factor and as a chemoattractant for endothelial cells through activation of its receptor, Eck/Sek2 (Pandey et al., 1995b) . Some of the Eph-related receptors expressed in the nervous system have been predicted to play a role in axonogenesis. The Nuk receptor tyrosine kinase (a mouse homologue of chick Cek5 and rat Erk), transiently expressed within the axonal ®bers, has been proposed to play a role in the axonal path®nding and/or fasciculation stages of axonogenesis (Henkemeyer et al., 1994) . A study of AL-1/RAGS function using in vitro cultures of cortical neurons expressing the Rek7 receptor tyrosine kinase, a rat homologue of mouse Bsk, has suggested that AL-1/RAGS functions actively to stimulate axon fasciculation (Winslow et al., 1995) . In addition, RAGS, a chick homologue of AL-1, was demonstrated to induce growth cone collapse and repulsion of retinal ganglion cell axons (Drescher et al., 1995) . Recently it was reported that, in mice lacking Nuk, axons of the anterior commissure fail to reach their targets and project aberrantly to the¯oor of the brain . Therefore, axonal guidance and targeting may be one of the major functions in the nervous system of these receptor-ligand interactions.
To gain insight into the developmental functions of the receptor tyrosine kinases expressed in brain, we have isolated a full-length cDNA for mouse Eek, a member of the Eph subfamily of receptor tyrosine kinases. As a prelude to its functional analysis, we show here that the Eek receptor interacts with and is activated by three dierent GPI-anchored ligands highly expressed in the brain. Our results may suggest that Eek is able to trigger downstream, but yet unidenti®ed, signaling pathways by at least three dierent members of the Eph family ligands, namely Elf-1/Cek7-L, Ehk1-L/E¯-2/Lerk3 and AL-1/RAGS.
Results

Eek is a member of the Eph family
We have previously reported the identi®cation of tyrosine protein kinase sequences expressed in highly enriched cultures of rat embryonic hippocampal neurons (SaÂ nchez et al., 1994) . One of the tyrosine kinase receptor genes ampli®ed, denoted ptk-4, was found to be identical to the previously reported rat eek sequence (Chan and Watt, 1991) , which encodes a putative member of the Eph subfamily of receptor tyrosine kinases. However, only partial sequence encoding the kinase domain of Eek (Chan and Watt, 1991) has been reported to date. The rat eek gene is exclusively expressed in the brain (Chan and Watt, 1991) . Therefore, we screened a mouse brain cDNA library in order to recover clones encoding a fulllength Eek protein. The amino acid sequence for the Eek protein and its structure are shown in Figure 1a and b, respectively. The Eek protein contains an open reading frame encoding a 1004 amino acid-long polypeptide with all the hallmarks speci®c to the Eph family. A hydrophobic transmembrane domain (residues 541 to 561) divides the Eek protein into approximately two halves, a 540 amino acid extracellular region and a 443 amino acid cytoplasmic region containing a tyrosine kinase domain. Residues 1 to 27 of the Eek receptor are likely to correspond to its signal peptide (von Heijne, 1984) , whose cleavage should yield a mature protein of 977 amino acids. Within the putative extracellular domain of Eek, residues 53 to 124 encode an immunoglobulin-like domain, with highly conserved cysteine and tryptophan residues (O'Brian et al., 1991) . As with the insulin and EGF receptor family, the Eek extracellular domain has also a cysteine-rich region composed of 13 cysteine residues, the positions of which are conserved within the Eph family (Maisonpierre et al., 1993) . Residues 330 to 530, close to the transmembrane domain of the Eek protein, encode two ®bronectin type III (FNIII) repeats (O'Brian et al., 1991) . In addition, the extracellular domain of the Eek protein contains four consensus sites for N-linked glycosylation, NXT/S, predicting that the mature Eek protein is glycosylated.
To investigate the relationship between the Eek protein and other members of the Eph family, an amino acid cladogram based on the PILEUP program (GCG) was generated by the use of the Unweighted Pair Group Method with Arithmetic Mean Algorithm (UPGMA) (Nei, 1987) (Figure 2 ). We would infer from this tree that the Eek protein is closest related to a branch of the family that includes Ehk-3/MDK1 (Valenzuela et al., 1995; Ciossek et al., 1995) , Sek/ Cek8 , Ehk-2 (Maisonpierre et al., 1993) , Hek/Mek4/Cek4 (Sajjadi et al., 1991) and Bsk/Ehk1/Rek7/Cek7 (Zhou et al., 1994) .
Expression of the Eek receptor and the Eek-TrkB chimeric protein
To characterize the Eek protein in NIH3T3 cells, an expression vector encoding a full-length Eek protein was constructed as described in Materials and methods. The Eek construct was introduced into NIH3T3 cells and stable cell lines were established. No changes in cell morphology were apparent in these Eek expressing cells (data not shown). The representative cell line denoted 3T3-Eek, stably expressing the highest amount of the Eek protein, was metabolically labeled with To establish a biological assay for functional ligand/ receptor interactions in ®broblasts, we also constructed a chimeric receptor, denoted Eek-TrkB, similar to the Eck chimeric receptor previously described (Davis et al., 1994) . The Eek-TrkB chimeric receptor consists of the extracellular domain of the Eek receptor and the transmembrane plus entire cytoplasmic domains of TrkB, which have been shown to eectively transform NIH3T3 cells (Klein et al., 1991) . The Eek-TrkB construct was transfected into NIH3T3 cells to establish stable cell lines. Lysates from one representative cell line denoted 3T3-Eek/TrkB or control cells were prepared for immunoprecipitation with a pan anti-Trk antibody (Martin-Zanca et al., 1989) followed by immunoblot analysis using anti-TrkB antibody (Klein et al., 1990) as a probe ( Figure 3b ). As we expected, the Eek-TrkB chimeric protein was highly expressed as 110 000 Da protein in stably transfected NIH3T3 cells but not control cells (Figure 3b ). This Eek/TrkB chimeric construct was able to induce focus formation in NIH3T3 cells in a dose-dependent manner (data not shown), suggesting that the NIH3T3 cells express endogenous ligands. Alternatively, over-expression of the Eek-TrkB chimeric protein may cause focus formation in NIH3T3 cells in a ligand-dependent manner.
NIH3T3 cells have endogenous ligands for the Eek receptor
To study putative ligands for the Eek receptor, an expression vector containing the extracellular ligandbinding domain fused to the Fc portion of human immunoglobulin G1, denoted Eek-IgG, was constructed. The Eek-IgG construct was transiently transfected into COS cells to obtain the soluble EekIgG proteins. The Eek-IgG chimeric protein, as well as the CD4-IgG protein (Zettlmeissl et al., 1990) used as a control, were recovered from the supernatants of transfected COS cells but not those of control cells ( Figure 4a ). The puri®ed soluble Eek-IgG chimeric protein was used as a probe in binding assays on NIH3T3 cells as described in Materials and methods. The Eek-IgG chimeric protein bound to the normal NIH3T3 cells with a signi®cant anity, whereas the binding of the Eek-IgG protein was greatly reduced to the NIH3T3 cells ectopically expressing Eek ( Figure  4b ). This is very likely because of competition between Eek-IgG and Eek for ligand on the cell surface. The Figure 2 Cladogram for the Eph subfamily of receptor tyrosine kinases. The whole amino acid sequence of Eek was compared with those of Ehk-2 (Maisonpierre et al., 1993) , Hek/Mek4/Cek4 (Sajjadi et al., 1991) , Bsk/Ehk1/Rek7/Cek7 (Zhou et al., 1994) , Ehk-3/MDK1 (Valenzuela et al., 1995; Ciossek et al., 1995) , Sek/ Cek8 (Gilardi-Hebenstreit et al., 1992), Elk/Cek6 (Letwin et al., 1988; Lhotak et al., 1991) , Cek5/Erk/Nuk (Henkemeyer et al., 1994) , Hek2/Sek4/Cek10 (Bohme et al., 1993) , Myk1 (Andres et al., 1994) , Eck/Sek2 (Lindberg and Hunter, 1990) , and Eph (Hirai et al., 1987) using the PILEUP program (GCG). The 42 amino acid insert, present between kinase motifs IV and V in the Ehk-2 kinase domain was deleted for comparison as previously described (Maisonpierre et al., 1993) . A tree of sequence similarity was subsequently generated using the Unweighted Pair Group Method with Arithmetic Mean Algorithm (UPGMA) (Nei, 1987) calculated for the multiple alignments. Species homologues are shown adjacent to the Eph family members used for alignment Immunoprecipitates were fractionated on a 7.5% SDS ± PAGE, transferred to an Immobilin membrane, probed with the 114-4 (anti-TrkB) antibody (Klein et al., 1990) and detected with 125 
Iprotein A and autoradiography
The Eek receptor protein tyrosine kinase S Park and MP Sa Â nchez binding activity of the CD4-IgG chimeric protein used as a control in this assay was not dependent on the expression of the Eek protein. These results suggest that endogenous Eek ligands may be expressed on the surface of NIH3T3 cells.
Many of the ligands for Eph-related receptors are membrane-bound through a GPI-anchor which can be released from the cell surface by phosphatidylinositolspeci®c phospholipase C (PI-PLC). Thus, the NIH3T3 cells were treated by PI-PLC prior to incubation with the Eek-IgG chimeric proteins for binding assays. As expected, the binding of the Eek-IgG chimeric protein to the cells, was greatly reduced regardless of the Eek expression (Figure 4b ), demonstrating that the NIH3T3 cells express endogenous GPI-linked Eek ligands. Therefore, the presence of these endogenous Eek ligands most likely caused transformation through an autocrine loop in foci assay using Eek-TrkB chimeric cDNA.
Three dierent GPI-linked Eph family ligands can bind to the Eek ectodomain
Seven dierent ligands for Eph-related receptors have been identi®ed to date (Pandey et al., 1995a; TessierLavigne, 1995; Friedman and O'Leary, 1996) . Comparison of the amino acid sequence of these ligands have shown that members of this Eph ligand family are highly homologous (Cheng and Flanagan, 1994; Beckman et al., 1994; Davis et al., 1994) . Therefore, we used degenerate oligonucleotides designed from conserved regions of the Eph family ligands to amplify related sequences from mouse brain cDNA since the expression of the Eek receptor is brain-speci®c. Three known ligands, Elf-1/Cek7-L (Cheng and Flanagan, 1994; Shao et al., 1995) , Ehk1-L/E¯-2/Lerk3 (Davis et al., 1994) and AL-1/RAGS (Winslow et al., 1995; Drescher et al., 1995) , were ampli®ed and subsequently their full-length cDNAs were cloned from a mouse brain cDNA library. To investigate whether these ligands can bind to the Eek receptor, we constructed expression vectors containing the entire coding sequence of the ligands, except for the hydrophobic sequence of each ligands fused to the Fc portion of human immunoglobulin G1 (Figure 5a ). These soluble ligand-IgG chimeric proteins, denoted Elf1-IgG, Ehk1L-IgG and AL1-IgG, were secreted into the supernatant of transfected COS cells (Figure 5b ). Under non-reducing conditions, the soluble ligandIgG chimeras were detected as dimers (data not shown), which may be important for the activation of their receptors as suggested previously (Davis et al., 1994) . The puri®ed ligand-IgG chimeric proteins were used as probes in binding assays. The ligand-IgG chimeric proteins exhibit very low levels of binding to NIH3T3 cells (Figure 6 ). However, the binding of the three ligand-IgG proteins to the Eek or Eek-TrkB expressing cells was greatly increased. The binding of the ligand-IgG proteins to the Eek-TrkB expressing cell line was at least threefold higher as compared to the Eek expressing cell line, suggesting that more EekTrkB chimeric receptors are produced than the Eek receptors in NIH3T3 cells.
To compare the binding characteristics of three dierent ligands, the speci®c binding for the soluble The Eek receptor protein tyrosine kinase S Park and MP Sa Â nchez addition, the Eek receptor expressed in NIH3T3 cells is already highly phosphorylated on tyrosine residues, likely due to endogenous ligands that are capable of activating the receptor through an autocrine loop. In agreement with our binding data, the Eek receptor may be expressed at a lower level compared to the EekTrkB receptor in NIH3T3 cells. This may result in the saturation of tyrosine-phosphorylation of Eek, whereas Eek-TrkB is not maximally phosphorylated. As described above, the endogenous GPI-linked Eek ligands can be eliminated by treating PI-PLC. Indeed, when the cells expressing Eek-TrkB were treated with PI-PLC, the background tyrosine-phosphorylation of Eek-TrkB was signi®cantly reduced (data not shown). Therefore, the cells expressing the Eek receptor were treated with PI-PLC and stimulated with the three dierent ligand-IgG chimeric proteins prior to preparing cell lysates for immunoprecipitation with anti-Eek antibody. As expected, an immunoblot with the antiphosphotyrosine antibody revealed that the tyrosinephosphorylation of the Eek receptor was signi®cantly elevated, compared to the same proteins from unstimulated cells (Figure 8b, top panel) . An immunoblot using anti-Eek antibody as a probe showed that similar amounts of Eek were present in the immunoprecipitates (Figure 8b, bottom panel) . Together, these results demonstrate that three dierent GPI-linked ligands can activate the tyrosine kinase activity of the Eek receptor.
Discussion
Our molecular cloning of the full-length mouse eek gene establishes that the partially characterized Eek protein (Chan and Watt, 1991 ) is a novel member of the Eph subfamily of receptor tyrosine kinases. More than thirteen distinct members of this receptor subfamily have been reported to date, establishing the Eph family as the largest group among the receptor tyrosine kinase subfamilies (Tuzi and Gullick, 1994; Pandey et al., 1995a; Friedman and O'Leary, 1996) . The UPGMA tree by alignment of the Eek amino acid sequence with the sequences of other full-length Eph family members, shows that the Eek protein shares greater overall similarity to some members, including Ehk-3/MDK1 (Ciossek et al., 1995; Valenzuela et al., 1995) , Sek/Cek8 (GilardiHebenstreit et al., 1992; Nieto et al., 1992) , Ehk-2 (Maisonpierre et al., 1993) , Hek/Mek4/Cek4 (Sajjadi et al., 1991; Sajjadi and Pasquale, 1993) and Bsk/ Ehk1/Rek7/Cek7 (Maisonpierre et al., 1993; Zhou et al., 1994) . Interestingly, these receptors closely related to Eek are predominantly expressed in the nervous system. In addition, our in situ hybridization analysis and studies using mice carrying a null eek allele with a bacterial lacZ gene have demonstrated that eek gene is exclusively expressed in the central nervous system (manuscript in preparation). Although many of the Eph-related receptors are expressed in the nervous system, their expression patterns are quite distinct as well as overlapping, suggesting that the dierent neuronally expressed Eph family members may have complementary and overlapping roles in the development of various neuronal cell populations. Earlier studies suggest that some of the Eph-like receptors may be involved in oncogenic transformation (Hirai et al., 1987; Maru et al., 1990; Kiyokawa et al., 1994) . However, our results indicate that overexpression of Eek and its elevated level of tyrosine phosphorylation do not cause transformation of NIH3T3 cells. This is more consistent with recent reports that the Eph family tyrosine kinases signals through non-mitogenic pathways distinct from those involved in other tyrosine kinase receptor signaling (Lhotak and Pawson, 1993; Brambilla et al., 1995) .
Interestingly, we consistently observed that the extracellular domain of Eek binds to the normal NIH3T3 cells with a signi®cant anity but much less to the cells expressing the Eek receptor, whereas its binding activity was almost completely eliminated by the treatment of PI-PLC. In addition, NIH3T3 cells are easily transformed by the Eek-TrkB chimeric construct even without any exogenous ligands. These results indicate that NIH3T3 cells may express endogenous ligands for the Eek receptor. This is also consistent with the result that the Eek expressed in NIH3T3 cells is highly tyrosine-phosphorylated without stimulation with any exogenous ligands. Since the Eek receptor is exclusively present in the brain, including the midbrain tectum (manuscript in preparation), its ligands are likely to be localized in the brain. Three dierent Eph family ligands were ampli®ed from mouse brain cDNA using degenerate oligo PCR method. This is consistent with the reports that these three Eph family ligands are highly expressed in the brain. Elf-1/Cek7-L is highly expressed at the midbrain tectum in a decreasing caudal-rostral gradient (Cheng and Flanagan, 1994; Cheng et al., 1995) . AL-1/RAGS is also highly expressed in the caudal tectum (Drescher et al., 1995) . Ehk1-L/E¯-2/Lerk3 is highly expressed in the brain although its speci®c localization in the brain has not yet been reported (Davis et al., 1994) . These molecules may be physiologically relevant ligands for the Eek receptor. Our studies using the ectodomain-IgG fusion proteins of three dierent Eph family ligands demonstrated that these ligands are capable of binding to the Eek receptor with high and similar nM anities. Moreover, we con®rmed the presence of AL-1/RAGS transcripts in wild-type NIH3T3 cells by RT ± PCR (data not shown). However, it remains to be determined whether there are additional GPI-linked Eph family ligands interacting with the Eek receptor in NIH3T3 cells. More importantly, the binding of these soluble ligands can stimulate the tyrosine kinase activity of the Eek receptor. Previous studies indicate that ligands for Eph-like receptor tyrosine kinases require membrane attachment or clustering to activate their receptors (Davis et al., 1994) . Our recent preliminary experiments have also indicated that the monomeric soluble ligand proteins tagged with an epitope do not eciently activate the tyrosine kinase activity of Eek (data not shown), suggesting that the Eek receptor may also require dimerized or aggregated ligands for its activation. Recently it was reported that Eph-like receptors and ligands comprise two major speci®city subclasses (Gale et al., 1996) . Our data suggest that the Eek receptor is rather speci®c for GPI-linked ligands. Not surprisingly, the Eek receptor shows more signi®cant homology with the Eck-related subclass rather than Elkrelated subclass (Gale et al., 1996) . However, it remains to be determined whether the Eek receptor crosses ligand subclasses and binds transmembrane ligands with signi®cant anity. In summary, our ®ndings provide evidence that the Eek receptor can be activated by at least three dierent GPI-anchored Eph family ligands. The determination of which ligands are more physiologically relevant in vivo requires additional data, including colocalization and genetic analysis using knock-out mice. Nevertheless, our studies on the interactions between the Eek receptor and three dierent GPI-linked ligands should facilitate further studies directed toward understanding how the Eek receptor supports the development of the neuronal cells in the brain.
Materials and methods
Isolation of cDNA clones for eek and Eph family ligands
A lgt10 mouse brain cDNA library (Stratagene) was screened with a 32 P-labeled 200 bp EcoRI/NotI probe derived from a plasmid containing the eek PCR-ampli®ed clone (pPT16). Two recombinant phages were isolated, and their respective inserts were subcloned into pBluescript (pMS5 and pMS31) and submitted for nucleotide sequence analysis using the Sequenase system (United States Biochemical). Because none of these cDNA clones contained the complete eek coding sequence, a 280 bp EcoRI/XhoI probe derived from the 5' region of pMS31 was used to screen a dierent lgt10 mouse brain cDNA library (Clontech). One clone (pSP26) contained the missing 5' cDNA coding sequences. A 420 bp EcoRI/KpnI fragment corresponding to the 5' region of pSP26 was ligated to a 2825 bp KpnI/EcoRI DNA fragment from pMS31 and inserted into pBluescript to generate a fulllength eek cDNA clone (pSP38).
Total RNA (5 mg) was isolated from an embryonic day 15 mouse brain and used to synthesize cDNA with random primers and the Superscript cDNA Synthesis System (GIBCO/ BRL). The resulting cDNA was subjected to PCR-aided ampli®cation with the following degenerate primers designed from the conserved sequences of the published ligands, B61 (Holzman et al., 1990) , Lerk-2 (Beckman et al., 1994) and Elf-1 (Cheng and Flanagan, 1994) :
) as downstream primers. These ampli®ers contain EcoRI and BamHI cleavage sites (underlined) in their 5' regions for subcloning purposes. The PCR was performed using AmpliTaq polymerase (Perkin Elmer Cetus) and 40 cycles of ampli®cation with a 1 min denaturation step at 948C, a 2 min annealing step at 458C and a 2 min extension step at 658C. The resulting PCR products were resolved on 2% agarose gel and the major 150 bp or 260 bp bands were isolated by eletroelution. These PCR products were digested with EcoRI and BamHI and subcloned into pBluescript. DNAs obtained from randomly selected bacterial transformants were analysed by DNA sequencing.
The entire coding sequence of Elf-1/Cek7-L was ampli®ed from mouse brain cDNA by PCR using the following 5' and 3' ampli®ers designed from the published sequence Elf-1 (Cheng and Flanagan, 1994) : 5'-CCGGAATTCGC-CATGGCGCCCGCGCAGCGCCCG-3' (upstream primer, nucleotides 7 ± 24 of the published Elf-1 sequence) and 5'-CCCAAGCTTGGCCTGACACTAGGAGCCCAGAA -3' (downstream primer, nucleotides 628 ± 650 of the published Elf-1 sequence). A 650 bp EcoRI/HindIII restricted PCR product was subcloned into pBluescript (pSP42) and its entire sequence was con®rmed by DNA sequencing.
The 147 bp and 253 bp probes derived from PCRampli®ed clones containing partial sequences of Ehk1-L and AL-1, respectively, were used to screen a lgt10 mouse brain cDNA library (Clontech). Recombinant phages were isolated, and their respective inserts were subcloned into pBluescript for DNA sequencing analysis. The Ehk1-L and AL-1 cDNA containing their entire coding sequences were recovered as a 1042 bp XbaI/KpnI DNA fragment and a 1161 bp BssHII/XbaI DNA fragment, respectively, by subcloning into pBK-CMV (Stratagene) (pSP49 and pJF1).
Construction of expression vectors
pSP39 was generated by subcloning the entire 3245 bp EcoRI restricted eek cDNA insert of pSP38 into the unique EcoRI site of the pMEXneo mammalian expression vector (Martin-Zanca et al., 1989) .
The extracellular region of the eek gene was constructed by ligating a 1112 bp EcoRI/XhoI fragment from pSP38 to a 586 bp XhoI/BamHI restricted PCR product ampli®ed using the following 5' and 3' amplimers: 5'-CCGCTC-GAGTGGGCCCCTCCTCT-3' (upstream primer, nucleotides 1112 ± 1131 of the insert in pSP38) and 5'CGC-GGATCCGAGTGTCGTAGCGGGGC-3' (downstream primer, nucleotides 1698 ± 1680 of the insert in pSP38). The intracellular region of the mouse trkB gene including its transmembrane domain was generated as a 1207 bp BamHI/ KpnI restricted PCR product ampli®ed using the following 5' and 3' amplimers: 5'-CGCGGATCCTCTCTCGGTCTAT-GCCGT-3' (upstream primer, nucleotides 1798 ± 1815 of the insert in pFRK43; Klein et al., 1989) and 5'-CGGGGTACC-AAGGACGGTCTGGGCAGA-3' (downstream primer, nucleotides 3004 ± 2987 of the insert in pFRK43 (Klein et al., 1989) ). The extracellular region of the eek gene and the transmembrane plus intracellular region of the trkB gene were inserted together into the EcoRI/KpnI restricted pMEXneo mammalian expression vector to generate the Eek-TrkB chimera (pSP54).
A 1698 bp DNA fragment containing the extracellular region of the eek gene described above was subcloned into the XhoI/BamHI site in the pCDM7B (Zettlmeiss et al., 1990) instead of the CD4 sequence to generate an Eek-IgG chimera (pSP51). To generate an Elf1-IgG chimera, a 567 bp PstI DNA fragment in pSP42 was subcloned into pBluescript so that the 5' and 3' ends of the Elf-1 cDNA are close to the XhoI and BamHI restriction sites in the polylinker region, respectively. Subsequently, a 600 bp XhoI/BamHI fragment containing the extracellular region of Elf-1 was subcloned into the pCDM7B vector (pSP55). Both Ehk1L-IgG and AL1-IgG chimeric constructs were made by generating their entire regions except for hydrophobic regions by PCR. For Ehk1-L, a 655 bp PCR product was ampli®ed using the following 5' and 3' ampli®ers: 5'-CCG-CTCGAGGCGGCGGCGGCTCCGGGGATGGCGGCG-3' (upstream primer) and 5'-CGCGGATCCGTTCCCGCTT-GGGGCTGGTCCCACT-3' (downstream primer). For AL-1, 656 bp PCR product was ampli®ed using the following 5' and 3' amplimers: 5'-CCGCTCGAG-CCG-CCGCTGGCTAGGCGTGATGTTGC-3' (upstream primer) and 5'-CGCGGATCCCGGCTGGGTATCCTTGGTGTC-TGCG-3' (downstream primer). Subsequently, the XhoI/ BamHI-restricted PCR products were subcloned into the pCDM7B vector to generate Ehk1L-IgG (pSP56) and AL1-IgG (pSP57) chimera. All the sequences generated by PCR described above were sequenced to exclude the possibility of errors by the polymerase. A segment of the amino acid sequence at the junction region for each chimeric construct is listed below with the junction point indicated`/'.
Transfection and protein expression NIH3T3 cells were transfected with various amounts of linearized expression vectors by the calcium phosphate precipitation technique (Graham and van der Eb, 1973) . G418-resistant colonies were selected and expanded in DMEM supplemented with 10% calf serum containing 500 mg of G418 per ml. The IgG chimera expression plasmids were transfected into COS cells using the DEAE-dextran/chloroquine method as described (Jing et al., 1992) . At 24 h after transfection, the culture medium was replaced with serum-free DMEM and continued for 3 days, at which time the conditioned medium was collected for IgG chimeric protein puri®cation. The IgG chimeric proteins were puri®ed using protein A-agarose column (MAPS II Kit, Bio-Rad), according to the manual.
Labeling, phosphorylation, immunoprecipitation and Western blot
For NIH3T3 cells, subcon¯uent cultures in 10 cm dishes were labeled with 35 S-Translabel (ICN) for 4 h in methionine-and cysteine-free DMEM containing 10% dialyzed calf serum (Gibco). Cells were lysed in RIPA buer and incubated for 1 h with the antibodies as described before (SaÂ nchez et al., 1994) . The resulting immune complexes were precipitated with Protein ASepharose (Pharmacia) and resolved on 7.5% SDS ± PAGE polyacrylamide gels. For Western blot using antiphosphotyrosine antibody (UBI), the secondary antibody used was 125 I-labeled sheep anti-mouse IgG (NEN). For Western blot using Rabbit polyclonal antiserum, 125 Ilabeled Protein A (NEN) was used for antibody detection.
COS cells expressing IgG chimeric proteins were incubated with 35 S-Translabel for 6 h in the media described above at 48 h after transfection. The supernatant was collected for immunoprecipitation using Protein A-Sepharose. The labeled proteins were resolved on either 7.5 or 10% SDS ± PAGE polyacrylamide gel and visualized by autoradiography.
To induce tyrosine-phosphorylation of Eek and Eek-TrkB, 1610 6 NIH3T3 cells were seeded into collagen-coated 10 cm plates and placed in 16DMEM containing 0.5% calf serum for 48 h. In some experiments, to remove GPI-linked endogenous ligand, cells were treated with PI-PLC (Sigma) as described below prior to incubating with 20 nM of the appropriate ligand-IgG chimeric proteins for 15 min at 378C.
Binding assay and PI-PLC treatment
For binding studies, NIH3T3 cells were seeded into collagen-coated 24-well plates (5610 4 cells/well). Two days later, cells were incubated with the appropriate IgG chimeric proteins in 16DMEM containing 10% calf serum for 30 min at 378C. For the indirect Scatchard analysis, cells were incubated with various concentrations of ligand chimeric proteins, whereas saturating concentrations of IgG chimeric proteins were used for determining their relative binding activity: 20 nM of Eek-IgG and 40 nM of ligand-IgG chimeric proteins, respectively. Addition of 20 nM of CD4-IgG was included in the binding assay as a control to exclude the binding due to the Fc portion of chimeric protein. Subsequently, the cells were washed with 16DMEM containing 10% calf serum and incubated with 1 mCi/ml of 125 I-labeled goat antihuman IgG antibody (NEN) for 30 min at 378C. Cells were washed two times with 16DMEM containing 10% calf serum, then solubilized by addition of 1N NaOH and the radioactivity was quanti®ed using a Beckman autogamma counter. In all assays, non-speci®c binding of 125 I-labeled antibody was assayed in the absence of the IgG chimera.
For experiments to remove GPI-anchor, cells were treated in a complete medium for 2 h at 378C with 1 U/ml of PI-PLC prior to adding IgG chimeric proteins.
Preparation of antisera
To generate a GST-Eek bacterial fusion protein expression vector (pBH3), a 642 bp PCR ampli®ed DNA fragment corresponding to the nucleotides 2464 to 3108 of the eek cDNA insert in pSP38 was subcloned into the GST-fusion protein expression vector pGEX-2TK (Pharmacia). The fusion proteins were puri®ed and used for immunizing rabbits.
